Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 3, 2020
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
[ Tue, Nov 03rd 2020
] - WOPRAI
Mon, November 2, 2020
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
[ Mon, Nov 02nd 2020
] - WOPRAI
Steven Valiquette Upgraded (CAH) to Buy and Held Target at $57 on, Nov 2nd, 2020
Steven Valiquette of Barclays, Upgraded "Cardinal Health, Inc." (CAH) to Buy and Held Target at $57 on, Nov 2nd, 2020.
Steven has made no other calls on CAH in the last 4 months.
There are 4 other peers that have a rating on CAH. Out of the 4 peers that are also analyzing CAH, 1 agrees with Steven's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Ricky Goldwasser of "Morgan Stanley" Maintained at Hold with Increased Target to $61 on, Friday, August 7th, 2020
These are the ratings of the 3 analyists that currently disagree with Steven
- George Hill of "Deutsche Bank" Upgraded from Hold to Strong Buy and Held Target at $61 on, Friday, September 25th, 2020
- Kevin Caliendo of "UBS" Maintained at Strong Buy with Decreased Target to $64 on, Monday, August 10th, 2020
- Michael Cherny of "B of A Securities" Maintained at Strong Buy with Increased Target to $63 on, Tuesday, July 21st, 2020
